The Intestinotrophic Peptide, GLP-2, Counteracts Intestinal Atrophy in Mice Induced by the Epidermal Growth Factor Receptor Inhibitor, Gefitinib

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-07-0574
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Gefitinib-Induced Cardiomyopathy in Epidermal Growth Receptor-Mutated NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Nursing Management of Epidermal Growth Factor Receptor Inhibitor-Induced Toxicities

Clinical Journal of Oncology Nursing
Oncology
2008English

Symmetrical Drug-Related Intertriginous and Flexural Exanthema Secondary to Epidermal Growth Factor Receptor Inhibitor Gefitinib

JAAD Case Reports
Dermatology
2020English

Epidermal Growth Factor Receptor Transactivation Is Required for Proteinase-Activated Receptor-2-Induced COX-2 Expression in Intestinal Epithelial Cells

American Journal of Physiology - Gastrointestinal and Liver Physiology
HepatologyPhysiologyGastroenterology
2012English

Autophagic Degradation of Epidermal Growth Factor Receptor in Gefitinib-Resistant Lung Cancer by Celastrol

International Journal of Oncology
Cancer ResearchOncology
2016English

Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer

Clinical Cancer Research
Cancer ResearchOncology
2004English

Glucagon-Like Peptide 2 (GLP-2) Accelerates the Growth of Colonic Neoplasms in Mice

Gut
Gastroenterology
2004English

Chemopreventive Effects of Gefitinib on Nonsmoking-Related Lung Tumorigenesis in Activating Epidermal Growth Factor Receptor Transgenic Mice

Cancer Research
Cancer ResearchOncology
2009English

COX-2/sEH Dual Inhibitor PTUPB Suppresses Glioblastoma Growth by Targeting Epidermal Growth Factor Receptor and Hyaluronan Mediated Motility Receptor

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy